Cure MSA

Country specific patient information

Alsemari A, Al-Hindi HN. Large-scale mitochondrial DNA deletion underlying familial multiple system atrophy of the cerebellar subtype. Clin Case Rep 2016;4:111-117.


Bi C, Qian H, Peng L, Xia D, Liu L, Wang Z, Qi X. [Analysis of serum lipid level in patients with multiple system atrophy]. Zhonghua Yi Xue Za Zhi 2015;95:3361-3365.


Kanemaru E, Terada S, Miura N. [Anesthetic Management of a Patient with Multiple System Atrophy--A Case Report]. Masui 2015;64:1258-1260.


Vieira BD, Radford RA, Chung RS, Guillemin GJ, Pountney DL. Neuroinflammation in Multiple System Atrophy: Response to and Cause of alpha-Synuclein Aggregation. Front Cell Neurosci 2015;9:437.


Tsuyusaki Y, Sakakibara R, Tateno F, Aiba Y, Kishi M, Tateno H, Ogata T, Inaoka T, Terada H, Suzuki Y. Multiple system atrophy presenting initially as spastic paraparesis. J Neurol Sci 2016;360:176-178.


Barbagallo G, Sierra-Pena M, Nemmi F, Traon AP, Meissner WG, Rascol O, Peran P. Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease. Mov Disord 2016;31:325-334.


Cao B, Wei QQ, Ou R, Yang J, Shang HF. Association of serum uric acid level with cognitive function among patients with multiple system atrophy. J Neurol Sci 2015;359:363-366.


Colosimo C, Berardelli A. Autonomic failure and reduced survival in multiple system atrophy. Brain 2015;138:3466-3468.


Zhao Q, Yang X, Tian S, An R, Zheng J, Xu Y. Association of the COQ2 V393A variant with risk of multiple system atrophy in East Asians: a case-control study and meta-analysis of the literature. Neurol Sci 2016;37:423-430.


Federoff M, Price TR, Sailer A, Scholz S, Hernandez D, Nicolas A, Singleton AB, Nalls M, Houlden H. Genome-wide estimate of the heritability of Multiple System Atrophy. Parkinsonism Relat Disord 2016;22:35-41.


Indelicato E, Fanciulli A, Poewe W, Antonini A, Pontieri FE, Wenning GK. Cerebral autoregulation and white matter lesions in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord 2015;21:1393-1397.


Calandra-Buonaura G, Doria A, Lopane G, Guaraldi P, Capellari S, Martinelli P, Cortelli P, Contin M. Pharmacodynamics of a low subacute levodopa dose helps distinguish between multiple system atrophy with predominant Parkinsonism and Parkinson's disease. J Neurol 2016;263:250-256.


Omichi R, Maeda Y, Sugaya A, Kataoka Y, Kariya S, Nagayasu R, Nakagawa A, Yamashita T, Abe K, Nishizaki K. Characteristics of audiogram configuration in multiple-system atrophy C and cortical cerebellar atrophy. Acta Otolaryngol 2016;136:266-270.


Hamada S, Takahashi R, Mishima M, Chin K. Use of a new generation of adaptive servo ventilation for sleep-disordered breathing in patients with multiple system atrophy. BMJ Case Rep 2015;2015.


Oguri M, Nakamura Y, Hara A, Kitano H, Motokura T. [A Patient with Early-Stage Multiple System Atrophy Showing Augmented Nystagmus in Light]. Rinsho Byori 2015;63:435-440.


Ueha R, Nito T, Sakamoto T, Yamauchi A, Tsunoda K, Yamasoba T. Post-operative swallowing in multiple system atrophy. Eur J Neurol 2016;23:393-400.


Brugger F, Jesus S, Ganos C, Bhatia KP. Episodic akinesia of jaw movements akin to freezing in multiple system atrophy. Parkinsonism Relat Disord 2015;21:1483-1484.


Kuzdas-Wood D, Irschick R, Theurl M, Malsch P, Mair N, Mantinger C, Wanschitz J, Klimaschewski L, Poewe W, Stefanova N, Wenning GK. Involvement of Peripheral Nerves in the Transgenic PLP-alpha-Syn Model of Multiple System Atrophy: Extending the Phenotype. PLoS One 2015;10:e0136575.


Lin DJ, Hermann KL, Schmahmann JD. The Diagnosis and Natural History of Multiple System Atrophy, Cerebellar Type. Cerebellum 2015.


Brudek T, Winge K, Rasmussen NB, Bahl JM, Tanassi J, Agander TK, Hyde TM, Pakkenberg B. Altered alpha-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains. J Neurochem 2016;136:172-185.


Salvesen L, Winge K, Brudek T, Agander TK, Lokkegaard A, Pakkenberg B. Neocortical Neuronal Loss in Patients with Multiple System Atrophy: A Stereological Study. Cereb Cortex 2015.


Armstrong RA. Quantitative pathological changes in the cerebellum of multiple system atrophy. Folia Neuropathol 2015;53:193-202.


Konishi H, Mizota T, Fukuda K. [Persistent Bilateral Vocal Cord Paralysis after General Anesthesia in a Patient with Multiple System Atrophy: A Case Report]. Masui 2015;64:651-654.


Cao B, Zhao B, Wei QQ, Chen K, Yang J, Ou R, Wu Y, Shang HF. The Global Cognition, Frontal Lobe Dysfunction and Behavior Changes in Chinese Patients with Multiple System Atrophy. PLoS One 2015;10:e0139773.


Ishibashi K, Nishina H, Ishiwata K, Ishii K. Individual time course of pre- and postsynaptic PET imaging may improve differential diagnosis of Parkinson's disease and multiple system atrophy: a case report. BMC Res Notes 2015;8:496.


Stomeo F, Rispoli V, Sensi M, Pastore A, Malagutti N, Pelucchi S. Subtotal arytenoidectomy for the treatment of laryngeal stridor in multiple system atrophy: phonatory and swallowing results. Braz J Otorhinolaryngol 2016;82:116-120.


Khan S, Moore J, Ealing J, Kobylecki C. Psychosis in a patient with probable multiple system atrophy of cerebellar type. J Neurol Sci 2015;358:501-502.


Spencer B, Valera E, Rockenstein E, Trejo-Morales M, Adame A, Masliah E. A brain-targeted, modified neurosin (kallikrein-6) reduces alpha-synuclein accumulation in a mouse model of multiple system atrophy. Mol Neurodegener 2015;10:48.


Kim HW, Kim JS, Oh M, Oh JS, Lee SJ, Oh SJ, Chung SJ, Lee CS. Different loss of dopamine transporter according to subtype of multiple system atrophy. Eur J Nucl Med Mol Imaging 2016;43:517-525.


Coon EA, Sletten DM, Suarez MD, Mandrekar JN, Ahlskog JE, Bower JH, Matsumoto JY, Silber MH, Benarroch EE, Fealey RD, Sandroni P, Low PA, Singer W. Clinical features and autonomic testing predict survival in multiple system atrophy. Brain 2015;138:3623-3631.


Kim HJ, Stamelou M, Jeon B. Multiple system atrophy-mimicking conditions: Diagnostic challenges. Parkinsonism Relat Disord 2016;22 Suppl 1:S12-15.


Mendoza-Santiesteban CE, Palma JA, Martinez J, Norcliffe-Kaufmann L, Hedges TR, 3rd, Kaufmann H. Progressive retinal structure abnormalities in multiple system atrophy. Mov Disord 2015;30:1944-1953.


Terao Y, Fukuda H, Tokushige S, Inomata-Terada S, Yugeta A, Hamada M, Ichikawa Y, Hanajima R, Ugawa Y. Is multiple system atrophy with cerebellar ataxia (MSA-C) like spinocerebellar ataxia and multiple system atrophy with parkinsonism (MSA-P) like Parkinson's disease? - A saccade study on pathophysiology. Clin Neurophysiol 2016;127:1491-1502.


Hwang I, Sohn CH, Kang KM, Jeon BS, Kim HJ, Choi SH, Yun TJ, Kim JH. Differentiation of Parkinsonism-Predominant Multiple System Atrophy from Idiopathic Parkinson Disease Using 3T Susceptibility-Weighted MR Imaging, Focusing on Putaminal Change and Lesion Asymmetry. AJNR Am J Neuroradiol 2015;36:2227-2234.


Nakamura K, Mori F, Kon T, Tanji K, Miki Y, Tomiyama M, Kurotaki H, Toyoshima Y, Kakita A, Takahashi H, Yamada M, Wakabayashi K. Accumulation of phosphorylated alpha-synuclein in subpial and periventricular astrocytes in multiple system atrophy of long duration. Neuropathology 2016;36:157-167.


Prusiner SB, Woerman AL, Mordes DA, Watts JC, Rampersaud R, Berry DB, Patel S, Oehler A, Lowe JK, Kravitz SN, Geschwind DH, Glidden DV, Halliday GM, Middleton LT, Gentleman SM, Grinberg LT, Giles K. Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci U S A 2015;112:E5308-5317.


Auzou N, Dujardin K, Biundo R, Foubert-Samier A, Barth C, Duval F, Tison F, Defebvre L, Antonini A, Meissner WG. Diagnosing dementia in multiple system atrophy by applying Movement Disorder Society diagnostic criteria for Parkinson's disease dementia. Parkinsonism Relat Disord 2015;21:1273-1277.


Chen Y, Cao B, Ou R, Chen X, Zhao B, Wei Q, Wu Y, Shang HF. Association analysis of the GRN rs5848 and MAPT rs242557 polymorphisms in Parkinson's disease and multiple system atrophy: a large-scale population-based study and meta-analysis. Int J Neurosci 2016;126:947-954.


Zhang S, Shi C, Mao C, Song B, Hou H, Wu J, Liu X, Luo H, Sun S, Xu Y. Plasma Homocysteine, Vitamin B12 and Folate Levels in Multiple System Atrophy: A Case-Control Study. PLoS One 2015;10:e0136468.


Schneeberger A, Tierney L, Mandler M. Active immunization therapies for Parkinson's disease and multiple system atrophy. Mov Disord 2016;31:214-224.


Bassil F, Monvoisin A, Canron MH, Vital A, Meissner WG, Tison F, Fernagut PO. Region-Specific Alterations of Matrix Metalloproteinase Activity in Multiple System Atrophy. Mov Disord 2015;30:1802-1812.


Chen Y, Cao B, Yang J, Wei Q, Ou RW, Zhao B, Song W, Guo X, Shang H. Analysis and meta-analysis of five polymorphisms of the LINGO1 and LINGO2 genes in Parkinson's disease and multiple system atrophy in a Chinese population. J Neurol 2015;262:2478-2483.


Miyoshi F, Kanasaki Y, Shinohara Y, Fujii S, Kaminou T, Tanabe Y, Ogawa T. Significance of combined use of MRI and perfusion SPECT for evaluation of multiple system atrophy, cerebellar type. Acta Radiol 2016;57:742-749.


Lee MJ, Shin JH, Seoung JK, Lee JH, Yoon U, Oh JH, Jung DS, Kim EJ. Cognitive impairments associated with morphological changes in cortical and subcortical structures in multiple system atrophy of the cerebellar type. Eur J Neurol 2016;23:92-100.


Ogaki K, Koga S, Aoki N, Lin W, Suzuki K, Ross OA, Dickson DW. Adult-onset cerebello-brainstem dominant form of X-linked adrenoleukodystrophy presenting as multiple system atrophy: case report and literature review. Neuropathology 2016;36:64-76.


Poewe W, Mahlknecht P, Krismer F. Therapeutic advances in multiple system atrophy and progressive supranuclear palsy. Mov Disord 2015;30:1528-1538.


Roy S, Srivastava AK, Jaryal AK, Deepak KK. Cardiovascular responses during cold pressor test are different in Parkinson disease and multiple system atrophy with parkinsonism. Clin Auton Res 2015;25:219-224.


Chen D, Wei X, Zou J, Wang R, Liu X, Xu X, Lu J, Wang Z, Tang B, Wang B, Jin K, Wang Q. Contra-Directional Expression of Serum Homocysteine and Uric Acid as Important Biomarkers of Multiple System Atrophy Severity: A Cross-Sectional Study. Front Cell Neurosci 2015;9:247.


Ji L, Wang Y, Zhu D, Liu W, Shi J. White matter differences between multiple system atrophy (parkinsonian type) and Parkinson's disease: A diffusion tensor image study. Neuroscience 2015;305:109-116.


Chen Y, Wei QQ, Ou R, Cao B, Chen X, Zhao B, Guo X, Yang Y, Chen K, Wu Y, Song W, Shang HF. Genetic Variants of SNCA Are Associated with Susceptibility to Parkinson's Disease but Not Amyotrophic Lateral Sclerosis or Multiple System Atrophy in a Chinese Population. PLoS One 2015;10:e0133776.


Halliday GM. Re-evaluating the glio-centric view of multiple system atrophy by highlighting the neuronal involvement. Brain 2015;138:2116-2119.


Taniguchi H, Nakayama H, Hori K, Nishizawa M, Inoue M, Shimohata T. Esophageal Involvement in Multiple System Atrophy. Dysphagia 2015;30:669-673.


Kim JS, Yang JJ, Lee DK, Lee JM, Youn J, Cho JW. Cognitive Impairment and Its Structural Correlates in the Parkinsonian Subtype of Multiple System Atrophy. Neurodegener Dis 2015;15:294-300.


Poewe W, Krismer F. Neurodegenerative disease: Multiple system atrophy-new insight from prospective studies. Nat Rev Neurol 2015;11:430-431.


Kaindlstorfer C, Sommer P, Georgievska B, Mather RJ, Kugler AR, Poewe W, Wenning GK, Stefanova N. Failure of Neuroprotection Despite Microglial Suppression by Delayed-Start Myeloperoxidase Inhibition in a Model of Advanced Multiple System Atrophy: Clinical Implications. Neurotox Res 2015;28:185-194.


Fukui Y, Hishikawa N, Sato K, Kono S, Matsuzono K, Nakano Y, Ohta Y, Yamashita T, Deguchi K, Abe K. Dynamic Cerebrospinal Fluid Flow on MRI in Cortical Cerebellar Atrophy and Multiple System Atrophy-cerebellar Type. Intern Med 2015;54:1717-1723.


Doppler K, Weis J, Karl K, Ebert S, Ebentheuer J, Trenkwalder C, Klebe S, Volkmann J, Sommer C. Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy. Mov Disord 2015;30:1688-1692.


Xiang X, Hou X, Sun Z, Zhou G, Tang B, Jiang H. [1H-proton magnetic resonance spectroscopy in patients with multiple system atrophy and cognitive dysfunction]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2015;40:639-645.


Takaya M, Atsumi M, Hirose T, Ishii K, Shirakawa O. Cognitive impairment before changes appear on [18F]-fluoro-D-glucose positron emission tomography images in a patient with possible early-stage cerebellar-predominant multiple system atrophy. Psychogeriatrics 2016;16:216-221.


Kon T, Miki Y, Tanji K, Mori F, Tomiyama M, Toyoshima Y, Kakita A, Takahashi H, Utsumi J, Sasaki H, Wakabayashi K. Localization of nuclear receptor subfamily 4, group A, member 3 (NR4A3) in Lewy body disease and multiple system atrophy. Neuropathology 2015;35:503-509.


Wen XD, Li HF, Wang HX, Ni W, Dong Y, Wu ZY. Mutation Analysis of COQ2 in Chinese Patients with Cerebellar Subtype of Multiple System Atrophy. CNS Neurosci Ther 2015;21:626-630.


Benarroch EE, Schmeichel AM, Parisi JE, Low PA. Histaminergic tuberomammillary neuron loss in multiple system atrophy and dementia with Lewy bodies. Mov Disord 2015;30:1133-1139.


Franciotti R, Delli Pizzi S, Perfetti B, Tartaro A, Bonanni L, Thomas A, Weis L, Biundo R, Antonini A, Onofrj M. Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy. Mov Disord 2015;30:1237-1247.


Song IU, Yoo I, Chung YA, Jeong J. The value of brain perfusion SPECT for differentiation between mildly symptomatic idiopathic Parkinson's disease and the Parkinson variant of multiple system atrophy. Nucl Med Commun 2015;36:1049-1054.


Sumida K, Sato N, Ota M, Sakai K, Nippashi Y, Sone D, Yokoyama K, Ito K, Maikusa N, Imabayashi E, Matsuda H, Yamada K, Murata M, Kunimatsu A, Ohtomo K. Intraventricular cerebrospinal fluid temperature analysis using MR diffusion-weighted imaging thermometry in Parkinson's disease patients, multiple system atrophy patients, and healthy subjects. Brain Behav 2015;5:e00340.


Chen Y, Chen X, Guo X, Song W, Cao B, Wei Q, Ou R, Zhao B, Shang HF. Assessment of TREM2 rs75932628 association with Parkinson's disease and multiple system atrophy in a Chinese population. Neurol Sci 2015;36:1903-1906.


Suzuki J, Nakamura T, Hirayama M, Mizutani Y, Okada A, Ito M, Watanabe H, Sobue G. Impaired peripheral vasoconstrictor response to orthostatic stress in patients with multiple system atrophy. Parkinsonism Relat Disord 2015;21:917-922.


Hou X, Jiang H. [Advance in genetic research on multiple system atrophy]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2015;32:418-421.


Low PA, Reich SG, Jankovic J, Shults CW, Stern MB, Novak P, Tanner CM, Gilman S, Marshall FJ, Wooten F, Racette B, Chelimsky T, Singer W, Sletten DM, Sandroni P, Mandrekar J. Natural history of multiple system atrophy in the USA: a prospective cohort study. Lancet Neurol 2015;14:710-719.


Krismer F, Wenning GK. Multiple system atrophy in the USA: another piece in the jigsaw. Lancet Neurol 2015;14:672-674.


Zange L, Noack C, Hahn K, Stenzel W, Lipp A. Phosphorylated alpha-synuclein in skin nerve fibres differentiates Parkinson's disease from multiple system atrophy. Brain 2015;138:2310-2321.


Lee JH, Kim TH, Mun CW, Kim TH, Han YH. Progression of subcortical atrophy and iron deposition in multiple system atrophy: a comparison between clinical subtypes. J Neurol 2015;262:1876-1882.


Pukass K, Richter-Landsberg C. Inhibition of UCH-L1 in oligodendroglial cells results in microtubule stabilization and prevents alpha-synuclein aggregate formation by activating the autophagic pathway: implications for multiple system atrophy. Front Cell Neurosci 2015;9:163.


Huh YE, Park J, Suh MK, Lee SE, Kim J, Jeong Y, Kim HT, Cho JW. Differences in early speech patterns between Parkinson variant of multiple system atrophy and Parkinson's disease. Brain Lang 2015;147:14-20.


Nakamura K, Mori F, Kon T, Tanji K, Miki Y, Tomiyama M, Kurotaki H, Toyoshima Y, Kakita A, Takahashi H, Yamada M, Wakabayashi K. Filamentous aggregations of phosphorylated alpha-synuclein in Schwann cells (Schwann cell cytoplasmic inclusions) in multiple system atrophy. Acta Neuropathol Commun 2015;3:29.


Laurens B, Constantinescu R, Freeman R, Gerhard A, Jellinger K, Jeromin A, Krismer F, Mollenhauer B, Schlossmacher MG, Shaw LM, Verbeek MM, Wenning GK, Winge K, Zhang J, Meissner WG. Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative. Neurobiol Dis 2015;80:29-41.


Cykowski MD, Coon EA, Powell SZ, Jenkins SM, Benarroch EE, Low PA, Schmeichel AM, Parisi JE. Expanding the spectrum of neuronal pathology in multiple system atrophy. Brain 2015;138:2293-2309.


Pavy-Le Traon A, Piedvache A, Perez-Lloret S, Calandra-Buonaura G, Cochen-De Cock V, Colosimo C, Cortelli P, Debs R, Duerr S, Fanciulli A, Foubert-Samier A, Gerdelat A, Gurevich T, Krismer F, Poewe W, Tison F, Tranchant C, Wenning G, Rascol O, Meissner WG, European MSASG. New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study. J Neurol Neurosurg Psychiatry 2016;87:554-561.


Wang X, Ma M, Teng J, Zhang J, Zhou S, Zhang Y, Wu E, Ding X. Chronic exposure to cerebrospinal fluid of multiple system atrophy in neuroblastoma and glioblastoma cells induces cytotoxicity via ER stress and autophagy activation. Oncotarget 2015;6:13278-13294.


Aoki N, Boyer PJ, Lund C, Lin WL, Koga S, Ross OA, Weiner M, Lipton A, Powers JM, White CL, 3rd, Dickson DW. Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with alpha-synuclein. Acta Neuropathol 2015;130:93-105.


Haga R, Sugimoto K, Nishijima H, Miki Y, Suzuki C, Wakabayashi K, Baba M, Yagihashi S, Tomiyama M. Clinical Utility of Skin Biopsy in Differentiating between Parkinson's Disease and Multiple System Atrophy. Parkinsons Dis 2015;2015:167038.


Mahmud A, Strens LH, Tedla M. Laser arytenoidectomy and posterior cordotomy in a patient with bilateral vocal cord paralysis due to multiple system atrophy. BMJ Case Rep 2015;2015.


Sun Z, Jiang H, Jiao B, Hou X, Shen L, Xia K, Tang B. C9orf72 hexanucleotide expansion analysis in Chinese patients with multiple system atrophy. Parkinsonism Relat Disord 2015;21:811-812.


Sakushima K, Nishimoto N, Nojima M, Matsushima M, Yabe I, Sato N, Mori M, Sasaki H. Epidemiology of Multiple System Atrophy in Hokkaido, the Northernmost Island of Japan. Cerebellum 2015;14:682-687.


Mitsui J, Matsukawa T, Sasaki H, Yabe I, Matsushima M, Durr A, Brice A, Takashima H, Kikuchi A, Aoki M, Ishiura H, Yasuda T, Date H, Ahsan B, Iwata A, Goto J, Ichikawa Y, Nakahara Y, Momose Y, Takahashi Y, Hara K, Kakita A, Yamada M, Takahashi H, Onodera O, Nishizawa M, Watanabe H, Ito M, Sobue G, Ishikawa K, Mizusawa H, Kanai K, Hattori T, Kuwabara S, Arai K, Koyano S, Kuroiwa Y, Hasegawa K, Yuasa T, Yasui K, Nakashima K, Ito H, Izumi Y, Kaji R, Kato T, Kusunoki S, Osaki Y, Horiuchi M, Kondo T, Murayama S, Hattori N, Yamamoto M, Murata M, Satake W, Toda T, Filla A, Klockgether T, Wullner U, Nicholson G, Gilman S, Tanner CM, Kukull WA, Stern MB, Lee VM, Trojanowski JQ, Masliah E, Low PA, Sandroni P, Ozelius LJ, Foroud T, Tsuji S. Variants associated with Gaucher disease in multiple system atrophy. Ann Clin Transl Neurol 2015;2:417-426.


Mandler M, Valera E, Rockenstein E, Mante M, Weninger H, Patrick C, Adame A, Schmidhuber S, Santic R, Schneeberger A, Schmidt W, Mattner F, Masliah E. Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy. Mol Neurodegener 2015;10:10.


Kass-Iliyya L, Kobylecki C, McDonald KR, Gerhard A, Silverdale MA. Pain in multiple system atrophy and progressive supranuclear palsy compared to Parkinson's disease. Brain Behav 2015;5:e00320.


Norcliffe-Kaufmann L, Palma JA, Krismer F. Multiple system atrophy: the case for an international collaborative effort. Clin Auton Res 2015;25:81-83.


Ling H, Asi YT, Petrovic IN, Ahmed Z, Prashanth LK, Hazrati LN, Nishizawa M, Ozawa T, Lang A, Lees AJ, Revesz T, Holton JL. Minimal change multiple system atrophy: an aggressive variant? Mov Disord 2015;30:960-967.


Deguchi K, Ikeda K, Kume K, Takata T, Kokudo Y, Kamada M, Touge T, Honjo N, Masaki T. Significance of the hot-cross bun sign on T2*-weighted MRI for the diagnosis of multiple system atrophy. J Neurol 2015;262:1433-1439.


Jordan J, Kaufmann H. Focus on multiple system atrophy. Introduction. Clin Auton Res 2015;25:1-2.


Babu DS. Multiple-system atrophy. N Engl J Med 2015;372:1375.


Peyronnet B, Manunta A, Game X. Multiple-system atrophy. N Engl J Med 2015;372:1374-1375.


Gazulla J, Berciano J. Multiple-system atrophy. N Engl J Med 2015;372:1374.


Fanciulli A, Wenning GK. Multiple-system atrophy. N Engl J Med 2015;372:1375-1376.


Goldstein DS, Sullivan P, Holmes C, Kopin IJ, Sharabi Y, Mash DC. Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy. Parkinsonism Relat Disord 2015;21:567-572.


Nagaoka U, Shimizu T, Uchihara T. Leptin upregulation in advanced multiple system atrophy with hypocholesterolemia and unexpected fat accumulation. Neurol Sci 2015;36:1471-1477.


Chou YH, You H, Wang H, Zhao YP, Hou B, Chen NK, Feng F. Effect of Repetitive Transcranial Magnetic Stimulation on fMRI Resting-State Connectivity in Multiple System Atrophy. Brain Connect 2015;5:451-459.


Singer W, Low PA. Optimizing clinical trial design for multiple system atrophy: lessons from the rifampicin study. Clin Auton Res 2015;25:47-52.


Jordan J, Shibao C, Biaggioni I. Multiple system atrophy: using clinical pharmacology to reveal pathophysiology. Clin Auton Res 2015;25:53-59.


Ratti PL, Sierra-Pena M, Manni R, Simonetta-Moreau M, Bastin J, Mace H, Rascol O, David O. Distinctive features of NREM parasomnia behaviors in parkinson's disease and multiple system atrophy. PLoS One 2015;10:e0120973.


Ramli N, Nair SR, Ramli NM, Lim SY. Differentiating multiple-system atrophy from Parkinson's disease. Clin Radiol 2015;70:555-564.


Shiraishi W, Iwanaga Y, Yamamoto A. [A case of an anti-Ma2 antibody-positive patient presenting with variable CNS symptoms mimicking multiple system atrophy with a partial response to immunotherapy]. Rinsho Shinkeigaku 2015;55:96-100.


Palma JA, Fernandez-Cordon C, Coon EA, Low PA, Miglis MG, Jaradeh S, Bhaumik AK, Dayalu P, Urrestarazu E, Iriarte J, Biaggioni I, Kaufmann H. Prevalence of REM sleep behavior disorder in multiple system atrophy: a multicenter study and meta-analysis. Clin Auton Res 2015;25:69-75.


Radford R, Rcom-H'cheo-Gauthier A, Wong MB, Eaton ED, Quilty M, Blizzard C, Norazit A, Meedeniya A, Vickers JC, Gai WP, Guillemin GJ, West AK, Dickson TC, Chung R, Pountney DL. The degree of astrocyte activation in multiple system atrophy is inversely proportional to the distance to alpha-synuclein inclusions. Mol Cell Neurosci 2015;65:68-81.


Kawahara Y, Ikeda Y, Deguchi K, Kurata T, Hishikawa N, Sato K, Kono S, Yunoki T, Omote Y, Yamashita T, Abe K. Simultaneous assessment of cognitive and affective functions in multiple system atrophy and cortical cerebellar atrophy in relation to computerized touch-panel screening tests. J Neurol Sci 2015;351:24-30.


Mestre TA, Gupta A, Lang AE. MRI signs of multiple system atrophy preceding the clinical diagnosis: the case for an imaging-supported probable MSA diagnostic category. J Neurol Neurosurg Psychiatry 2016;87:443-444.


Lee JH, Han YH, Kang BM, Mun CW, Lee SJ, Baik SK. Erratum to: quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy. J Neurol 2015;262:798-800.


Federoff M, Schottlaender LV, Houlden H, Singleton A. Multiple system atrophy: the application of genetics in understanding etiology. Clin Auton Res 2015;25:19-36.


Rusz J, Bonnet C, Klempir J, Tykalova T, Baborova E, Novotny M, Rulseh A, Ruzicka E. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. J Neurol 2015;262:992-1001.


Goldstein DS, Kopin IJ, Sharabi Y, Holmes C. Plasma biomarkers of decreased vesicular storage distinguish Parkinson disease with orthostatic hypotension from the parkinsonian form of multiple system atrophy. Clin Auton Res 2015;25:61-67.


Sugiyama A, Ito S, Suichi T, Sakurai T, Mukai H, Yokota H, Yonezu T, Kuwabara S. Putaminal hypointensity on T2*-weighted MR imaging is the most practically useful sign in diagnosing multiple system atrophy: A preliminary study. J Neurol Sci 2015;349:174-178.


Tandon R, Pradhan S. Autonomic predominant multiple system atrophy in the context of Parkinsonian and cerebellar variants. Clin Neurol Neurosurg 2015;130:110-113.


Lin CH, Tan EK, Yang CC, Yi Z, Wu RM. COQ2 gene variants associate with cerebellar subtype of multiple system atrophy in Chinese. Mov Disord 2015;30:436-437.


Fanciulli A, Wenning GK. Multiple-system atrophy. N Engl J Med 2015;372:249-263.


Stefanova N, Wenning GK. Animal models of multiple system atrophy. Clin Auton Res 2015;25:9-17.


Quinn N. A short clinical history of multiple system atrophy. Clin Auton Res 2015;25:3-7.


Kim M, Jung JH, Park J, Son H, Jeong SJ, Oh SJ, Cho SY, Seoul National University Experts Of Urodynamics Leading Study G. Impaired detrusor contractility is the pathognomonic urodynamic finding of multiple system atrophy compared to idiopathic Parkinson's disease. Parkinsonism Relat Disord 2015;21:205-210.


Yuan X, Chen Y, Cao B, Zhao B, Wei Q, Guo X, Yang Y, Yuan L, Shang H. An association analysis of the R1628P and G2385R polymorphisms of the LRRK2 gene in multiple system atrophy in a Chinese population. Parkinsonism Relat Disord 2015;21:147-149.


Ozawa T, Sone H, Nishizawa M. Reply to: Relationship between leptin and blood pressure in patients with multiple system atrophy. J Neurol Sci 2015;348:285.


Agilli M, Aydin FN, Cayci T, Kurt YG. Relationship between leptin and blood pressure in patients with multiple system atrophy. J Neurol Sci 2015;348:284.


Galpern WR. Clinical trials for multiple system atrophy. Lancet Neurol 2015;14:126-127.


Poewe W, Seppi K, Fitzer-Attas CJ, Wenning GK, Gilman S, Low PA, Giladi N, Barone P, Sampaio C, Eyal E, Rascol O, Rasagiline-for MSAi. Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial. Lancet Neurol 2015;14:145-152.


Shao N, Yang J, Shang H. Voxelwise meta-analysis of gray matter anomalies in Parkinson variant of multiple system atrophy and Parkinson's disease using anatomic likelihood estimation. Neurosci Lett 2015;587:79-86.


Yoon RG, Kim SJ, Kim HS, Choi CG, Kim JS, Oh J, Chung SJ, Lee CS. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography. Neurosci Lett 2015;584:296-301.


Salvesen L, Ullerup BH, Sunay FB, Brudek T, Lokkegaard A, Agander TK, Winge K, Pakkenberg B. Changes in total cell numbers of the basal ganglia in patients with multiple system atrophy - A stereological study. Neurobiol Dis 2015;74:104-113.


Chen YP, Zhao B, Cao B, Song W, Guo X, Wei QQ, Yang Y, Yuan LX, Shang HF. Mutation scanning of the COQ2 gene in ethnic Chinese patients with multiple-system atrophy. Neurobiol Aging 2015;36:1222 e1227-1211.


Sun Z, Xiang X, Tang B, Chen Z, Peng H, Xia K, Jiang H. SNP rs11931074 of the SNCA gene may not be associated with multiple system atrophy in Chinese population. Int J Neurosci 2015;125:612-615.


Planetta PJ, Kurani AS, Shukla P, Prodoehl J, Corcos DM, Comella CL, McFarland NR, Okun MS, Vaillancourt DE. Distinct functional and macrostructural brain changes in Parkinson's disease and multiple system atrophy. Hum Brain Mapp 2015;36:1165-1179.


Sakurai K, Imabayashi E, Ito K, Tokumaru AM, Ozawa Y, Muto M, Nakagawa M, Okita K, Matsukawa N, Shibamoto Y. The utility of cerebral perfusion SPECT analysis using SPM8, eZIS and vbSEE for the diagnosis of multiple system atrophy-parkinsonism. Ann Nucl Med 2015;29:206-213.


McCann H, McGeachie AB, Silberstein P, Lewis SJ, Halliday GM. Restricted disease propagation in multiple system atrophy with prolonged survival. Neuropathol Appl Neurobiol 2015;41:681-685.


Mills JD, Kim WS, Halliday GM, Janitz M. Transcriptome analysis of grey and white matter cortical tissue in multiple system atrophy. Neurogenetics 2015;16:107-122.


Scholz SW, Majounie E, Revesz T, Holton JL, Okun MS, Houlden H, Singleton AB. Multiple system atrophy is not caused by C9orf72 hexanucleotide repeat expansions. Neurobiol Aging 2015;36:1223 e1221-1222.


Chen J, Mills JD, Halliday GM, Janitz M. Role of transcriptional control in multiple system atrophy. Neurobiol Aging 2015;36:394-400.


Jian F, Pan H, Zhang Z, Lin J, Chen N, Zhang L, Wu Q, Wang H, Wang Y, Cui L, Tang X. Sphincter electromyography in diabetes mellitus and multiple system atrophy. Neurourol Urodyn 2015;34:669-674.


Lee ST, Chu K, Jung KH, Ban JJ, Im WS, Jo HY, Park JH, Lim JY, Shin JW, Moon J, Lee SK, Kim M, Roh JK. Altered expression of miR-202 in cerebellum of multiple-system atrophy. Mol Neurobiol 2015;51:180-186.


Palma JA, Kaufmann H. Novel therapeutic approaches in multiple system atrophy. Clin Auton Res 2015;25:37-45.


Feng JY, Huang B, Yang WQ, Zhang YH, Wang LM, Wang LJ, Zhong XL. The putaminal abnormalities on 3.0T magnetic resonance imaging: can they separate parkinsonism-predominant multiple system atrophy from Parkinson's disease? Acta Radiol 2015;56:322-328.


Urbizu A, Canet-Pons J, Munoz-Marmol AM, Aldecoa I, Lopez MT, Compta Y, Alvarez R, Ispierto L, Tolosa E, Ariza A, Beyer K. Cystatin C is differentially involved in multiple system atrophy phenotypes. Neuropathol Appl Neurobiol 2015;41:507-519.


Yang H, Wang X, Liao W, Zhou G, Li L, Ouyang L. Application of diffusion tensor imaging in multiple system atrophy: the involvement of pontine transverse and longitudinal fibers. Int J Neurosci 2015;125:18-24.


Fellner L, Wenning GK, Stefanova N. Models of multiple system atrophy. Curr Top Behav Neurosci 2015;22:369-393.


Stetkarova I, Kofler M, Majerova V. Cutaneous silent periods in multiple system atrophy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2015;159:327-332.